Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2015 Filed Jul 17, 2015 13:27 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 175 | $34.98 | $6,121.50 |
DisclosureSEC source: 0001225208-15-015574 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,164 Underlying: Common Stock · 175 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2015 Filed Jul 17, 2015 13:27 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 4 | $34.98 | $139.92 |
DisclosureSEC source: 0001225208-15-015573 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,383 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2015 Filed Jul 17, 2015 13:27 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 134 | $34.98 | $4,687.32 |
DisclosureSEC source: 0001225208-15-015575 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,130 Underlying: Common Stock · 134 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2015 Filed Jul 14, 2015 22:54 UTC |
BOURLA ALBERTGroup President
|
GrantPhantom Stock Units SSP · Derivative | 28 | $34.82 | $974.96 |
DisclosureSEC source: 0001225208-15-015455 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,854 Underlying: Common Stock · 28 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2015 Filed Jul 14, 2015 22:54 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 18 | $34.82 | $626.76 |
DisclosureSEC source: 0001225208-15-015456 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,379 Underlying: Common Stock · 18 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2015 Filed Jul 14, 2015 22:54 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 237 | $34.82 | $8,252.34 |
DisclosureSEC source: 0001225208-15-015457 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,991 Underlying: Common Stock · 237 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2015 Filed Jul 14, 2015 22:54 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 604 | $34.82 | $21,031.28 |
DisclosureSEC source: 0001225208-15-015458 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,002 Underlying: Common Stock · 604 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 02, 2015 Filed Sep 29, 2015 19:29 UTC |
SANGER STEPHEN WDirector
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-018700 · doc4.xml · nonDerivative · entry 1 SANGER STEPHEN W · CIK 0001204994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust for Spouse Disclosed balance after: 85 Read SEC document |
| June 30, 2015 Filed Jul 1, 2015 17:42 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
Tax withholdingCommon Stock | 9,633 | $33.53 | $322,994.49 |
DisclosureSEC source: 0001225208-15-014509 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,254 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| June 30, 2015 Filed Jul 2, 2015 18:08 UTC |
BOURLA ALBERTGroup President
|
GrantPhantom Stock Units SSP · Derivative | 16 | $33.53 | $536.48 |
DisclosureSEC source: 0001225208-15-014903 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,827 Underlying: Common Stock · 16 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2015 Filed Jul 2, 2015 18:09 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 183 | $33.53 | $6,135.99 |
DisclosureSEC source: 0001225208-15-014905 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,763 Underlying: Common Stock · 183 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2015 Filed Jul 2, 2015 18:09 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 4 | $33.53 | $134.12 |
DisclosureSEC source: 0001225208-15-014904 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,362 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2015 Filed Jul 2, 2015 18:09 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 139 | $33.53 | $4,660.67 |
DisclosureSEC source: 0001225208-15-014906 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,428 Underlying: Common Stock · 139 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 26, 2015 Filed Jun 29, 2015 20:59 UTC |
KILTS JAMES MDirector
|
GrantPhantom Stock Units · Derivative | 1,197.671 | $33.92 | $40,625.00 |
DisclosureSEC source: 0001225208-15-014346 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,348.029 Underlying: Common Stock · 1,197.671 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 26, 2015 Filed Jun 29, 2015 20:54 UTC |
Echevarria JosephDirector
|
GrantPhantom Stock Units · Derivative | 66.818 | $33.92 | $2,266.47 |
DisclosureSEC source: 0001225208-15-014345 · doc4.xml · derivative · entry 2 Echevarria Joseph · CIK 0001633137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,843.42 Underlying: Common Stock · 66.818 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 26, 2015 Filed Jun 29, 2015 20:59 UTC |
NARAYEN SHANTANUDirector
|
GrantPhantom Stock Units · Derivative | 1,013.414 | $33.92 | $34,375.00 |
DisclosureSEC source: 0001225208-15-014347 · doc4.xml · derivative · entry 1 NARAYEN SHANTANU · CIK 0001224154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,032.466 Underlying: Common Stock · 1,013.414 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 26, 2015 Filed Jun 29, 2015 20:59 UTC |
SANGER STEPHEN WDirector
|
GrantPhantom Stock Units · Derivative | 1,197.671 | $33.92 | $40,625.00 |
DisclosureSEC source: 0001225208-15-014348 · doc4.xml · derivative · entry 1 SANGER STEPHEN W · CIK 0001204994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,918.733 Underlying: Common Stock · 1,197.671 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 26, 2015 Filed Jun 29, 2015 20:59 UTC |
SMITH JAMES CDirector
|
GrantPhantom Stock Units · Derivative | 976.563 | $33.92 | $33,125.02 |
DisclosureSEC source: 0001225208-15-014349 · doc4.xml · derivative · entry 1 SMITH JAMES C · CIK 0001611777 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,629.9612 Underlying: Common Stock · 976.563 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 25, 2015 Filed Jun 29, 2015 20:54 UTC |
Echevarria JosephDirector
|
GrantPhantom Stock Units · Derivative | 4,776.602 | $34.02 | $162,500.00 |
DisclosureSEC source: 0001225208-15-014345 · doc4.xml · derivative · entry 1 Echevarria Joseph · CIK 0001633137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,776.602 Underlying: Common Stock · 4,776.602 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 15, 2015 Filed Jun 16, 2015 20:20 UTC |
BOURLA ALBERTGroup President
|
GrantPhantom Stock Units SSP · Derivative | 16 | $34.04 | $544.64 |
DisclosureSEC source: 0001225208-15-013978 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,810 Underlying: Common Stock · 16 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2015 Filed Jun 16, 2015 20:20 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 4 | $34.04 | $136.16 |
DisclosureSEC source: 0001225208-15-013979 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,358 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2015 Filed Jun 16, 2015 20:21 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 137 | $34.04 | $4,663.48 |
DisclosureSEC source: 0001225208-15-013981 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,271 Underlying: Common Stock · 137 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2015 Filed Jun 16, 2015 20:21 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 180 | $34.04 | $6,127.20 |
DisclosureSEC source: 0001225208-15-013980 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,575 Underlying: Common Stock · 180 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 11, 2015 Filed Jun 12, 2015 13:26 UTC |
OLSON LAURIE JExecutive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 26,000 | $0.00 Strike: $25.87 | $0.00 |
DisclosureSEC source: 0001225208-15-013736 · doc4.xml · derivative · entry 9 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,000 shares Expires 2017-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options are fully exercisable. Read SEC document |
| June 11, 2015 Filed Jun 12, 2015 13:26 UTC |
OLSON LAURIE JExecutive Vice President
|
SaleCommon Stock | 12,100 | $34.40 | $416,240.00 |
DisclosureSEC source: 0001225208-15-013736 · doc4.xml · nonDerivative · entry 7 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,113 Read SEC document |
| June 11, 2015 Filed Jun 12, 2015 13:26 UTC |
OLSON LAURIE JExecutive Vice President
|
SaleCommon Stock | 6,900 | $34.38 | $237,222.00 |
DisclosureSEC source: 0001225208-15-013736 · doc4.xml · nonDerivative · entry 6 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,213 Read SEC document |
| June 11, 2015 Filed Jun 12, 2015 13:26 UTC |
OLSON LAURIE JExecutive Vice President
|
SaleCommon Stock | 5,500 | $34.39 | $189,145.00 |
DisclosureSEC source: 0001225208-15-013736 · doc4.xml · nonDerivative · entry 5 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,113 Read SEC document |
| June 11, 2015 Filed Jun 12, 2015 13:26 UTC |
OLSON LAURIE JExecutive Vice President
|
SaleCommon Stock | 900 | $34.37 | $30,933.00 |
DisclosureSEC source: 0001225208-15-013736 · doc4.xml · nonDerivative · entry 4 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,613 Read SEC document |
| June 11, 2015 Filed Jun 12, 2015 13:26 UTC |
OLSON LAURIE JExecutive Vice President
|
SaleCommon Stock | 500 | $34.36 | $17,180.00 |
DisclosureSEC source: 0001225208-15-013736 · doc4.xml · nonDerivative · entry 3 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,513 Read SEC document |
| June 11, 2015 Filed Jun 12, 2015 13:26 UTC |
OLSON LAURIE JExecutive Vice President
|
SaleCommon Stock | 100 | $34.35 | $3,435.00 |
DisclosureSEC source: 0001225208-15-013736 · doc4.xml · nonDerivative · entry 2 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 Read SEC document |
| June 11, 2015 Filed Jun 12, 2015 13:26 UTC |
OLSON LAURIE JExecutive Vice President
|
Exercise / conversionCommon Stock | 26,000 | $25.87 | $672,620.00 |
DisclosureSEC source: 0001225208-15-013736 · doc4.xml · nonDerivative · entry 1 OLSON LAURIE J · CIK 0001553231 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,113 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2015 Filed Jun 3, 2015 14:09 UTC |
HILL CHARLES HExecutive Vice President
|
OtherCommon Stock | 2,156 | $34.49 | $74,360.44 |
DisclosureSEC source: 0001225208-15-013251 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Rule 16b-3 Plan Disclosed balance after: 10,329 F1 · shares: This transaction constitutes an intra-plan transfer involving the Pfizer stock fund under the Company's Qualified Savings Plan. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 22:16 UTC |
BOURLA ALBERTGroup President
|
GrantPhantom Stock Units SSP · Derivative | 16 | $34.75 | $556.00 |
DisclosureSEC source: 0001225208-15-013086 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,794 Underlying: Common Stock · 16 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 22:16 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 4 | $34.75 | $139.00 |
DisclosureSEC source: 0001225208-15-013087 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,353 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 22:16 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 176 | $34.75 | $6,116.00 |
DisclosureSEC source: 0001225208-15-013088 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,387 Underlying: Common Stock · 176 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 22:16 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 135 | $34.75 | $4,691.25 |
DisclosureSEC source: 0001225208-15-013089 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,108 Underlying: Common Stock · 135 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 29, 2015 Filed Jun 2, 2015 20:54 UTC |
HILL CHARLES HExecutive Vice President
|
OtherPhantom Stock Units SSP · Derivative | 33,278 | $34.75 | $1,156,410.50 |
DisclosureSEC source: 0001225208-15-013178 · doc4.xml · derivative · entry 3 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,972 Underlying: Common Stock · 33,278 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F4 · derivative.underlying_shares: This transaction constitutes an intra-plan transfer involving the Pfizer stock unit fund under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan. Read SEC document |
| May 29, 2015 Filed Jun 2, 2015 20:54 UTC |
HILL CHARLES HExecutive Vice President
|
OtherCommon Stock | 7,489 | $34.75 | $260,242.75 |
DisclosureSEC source: 0001225208-15-013178 · doc4.xml · nonDerivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Rule 16b-3 Plan Disclosed balance after: 8,173 F1 · shares: This transaction constitutes an intra-plan transfer involving the Pfizer stock fund under the Company's Qualified Savings Plan. Read SEC document |
| May 29, 2015 Filed Jun 2, 2015 20:54 UTC |
HILL CHARLES HExecutive Vice President
|
SaleCommon Stock | 42,870 | $34.92 | $1,497,020.40 |
DisclosureSEC source: 0001225208-15-013178 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,357 Read SEC document |
| May 15, 2015 Filed May 18, 2015 22:14 UTC |
BOURLA ALBERTGroup President
|
GrantPhantom Stock Units SSP · Derivative | 16 | $33.99 | $543.84 |
DisclosureSEC source: 0001225208-15-012330 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,780 Underlying: Common Stock · 16 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2015 Filed May 18, 2015 22:14 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 4 | $33.99 | $135.96 |
DisclosureSEC source: 0001225208-15-012331 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,350 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2015 Filed May 18, 2015 22:14 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 180 | $33.99 | $6,118.20 |
DisclosureSEC source: 0001225208-15-012333 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,225 Underlying: Common Stock · 180 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2015 Filed May 18, 2015 22:14 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 138 | $33.99 | $4,690.62 |
DisclosureSEC source: 0001225208-15-012332 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,023 Underlying: Common Stock · 138 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2015 Filed May 1, 2015 21:05 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 4 | $33.93 | $135.72 |
DisclosureSEC source: 0001225208-15-010855 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,319 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2015 Filed May 1, 2015 21:05 UTC |
BOURLA ALBERTGroup President
|
GrantPhantom Stock Units SSP · Derivative | 16 | $33.93 | $542.88 |
DisclosureSEC source: 0001225208-15-010854 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,708 Underlying: Common Stock · 16 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2015 Filed May 1, 2015 21:05 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 181 | $33.93 | $6,141.33 |
DisclosureSEC source: 0001225208-15-010856 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,607 Underlying: Common Stock · 181 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2015 Filed May 1, 2015 21:05 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 138 | $33.93 | $4,682.34 |
DisclosureSEC source: 0001225208-15-010857 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,328 Underlying: Common Stock · 138 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 23, 2015 Filed Apr 24, 2015 18:00 UTC |
Ausiello Dennis ADirector
|
GrantPhantom Stock Units · Derivative | 4,595.588 | $35.36 | $162,499.99 |
DisclosureSEC source: 0001225208-15-010347 · doc4.xml · derivative · entry 1 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,887.024 Underlying: Common Stock · 4,595.588 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2015 Filed Apr 24, 2015 18:00 UTC |
CORNWELL W DONDirector
|
GrantPhantom Stock Units · Derivative | 4,595.588 | $35.36 | $162,499.99 |
DisclosureSEC source: 0001225208-15-010348 · doc4.xml · derivative · entry 1 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,185.09 Underlying: Common Stock · 4,595.588 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2015 Filed Apr 24, 2015 18:00 UTC |
NARAYEN SHANTANUDirector
|
GrantPhantom Stock Units · Derivative | 4,595.588 | $35.36 | $162,499.99 |
DisclosureSEC source: 0001225208-15-010352 · doc4.xml · derivative · entry 1 NARAYEN SHANTANU · CIK 0001224154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,841.734 Underlying: Common Stock · 4,595.588 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.